Figure 1: A flow diagram depicting the exploration of infliximab therapy response biomarker candidates in the published scientific literature and the search for transcriptomic datasets in GEO (www.ncbi.nlm.nih.gov/geo/) according to the PRISMA guidelines. (UC: Ulcerative Colitis, IBD: Inflammatory Bowel Disease, CD: Crohn’s Disease, JIA: Juvenile Idiopathic Arthritis, HUGO: Human Genome Organization Gene Nomenclature Committee)